1. Home
  2. OTLK vs YYGH Comparison

OTLK vs YYGH Comparison

Compare OTLK & YYGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTLK
  • YYGH
  • Stock Information
  • Founded
  • OTLK 2010
  • YYGH 2010
  • Country
  • OTLK United States
  • YYGH Singapore
  • Employees
  • OTLK N/A
  • YYGH N/A
  • Industry
  • OTLK Biotechnology: Biological Products (No Diagnostic Substances)
  • YYGH
  • Sector
  • OTLK Health Care
  • YYGH
  • Exchange
  • OTLK Nasdaq
  • YYGH NYSE
  • Market Cap
  • OTLK 48.3M
  • YYGH 40.2M
  • IPO Year
  • OTLK 2016
  • YYGH 2024
  • Fundamental
  • Price
  • OTLK $1.77
  • YYGH $1.37
  • Analyst Decision
  • OTLK Strong Buy
  • YYGH
  • Analyst Count
  • OTLK 5
  • YYGH 0
  • Target Price
  • OTLK $10.20
  • YYGH N/A
  • AVG Volume (30 Days)
  • OTLK 689.4K
  • YYGH 44.9K
  • Earning Date
  • OTLK 05-15-2025
  • YYGH 06-10-2025
  • Dividend Yield
  • OTLK N/A
  • YYGH N/A
  • EPS Growth
  • OTLK N/A
  • YYGH N/A
  • EPS
  • OTLK 0.83
  • YYGH N/A
  • Revenue
  • OTLK N/A
  • YYGH $41,103,389.00
  • Revenue This Year
  • OTLK N/A
  • YYGH N/A
  • Revenue Next Year
  • OTLK $288.46
  • YYGH N/A
  • P/E Ratio
  • OTLK $2.12
  • YYGH N/A
  • Revenue Growth
  • OTLK N/A
  • YYGH 29.37
  • 52 Week Low
  • OTLK $0.87
  • YYGH $0.72
  • 52 Week High
  • OTLK $9.25
  • YYGH $2.08
  • Technical
  • Relative Strength Index (RSI)
  • OTLK 57.64
  • YYGH N/A
  • Support Level
  • OTLK $1.55
  • YYGH N/A
  • Resistance Level
  • OTLK $1.90
  • YYGH N/A
  • Average True Range (ATR)
  • OTLK 0.18
  • YYGH 0.00
  • MACD
  • OTLK 0.01
  • YYGH 0.00
  • Stochastic Oscillator
  • OTLK 53.10
  • YYGH 0.00

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

About YYGH YY GROUP HOLDING LIMITED

YY Group Holding Ltd is a data and technology-driven company focused on developing enterprise intelligent labor matching services and smart cleaning services, founded in Singapore. Through its subsidiaries, it provides enterprise manpower outsourcing and smart cleaning services in Singapore, Malaysia, and other countries. The group's reportable segments are Manpower outsourcing services and Cleaning Service. Maximum revenue is generated from the Cleaning Service segment, which is engaged in acting as a contractor to provide long-term cleaning services to hotels and shopping malls, including the areas of toilets, common areas, bin centers, elevators, etc. Geographically, a majority of the group's revenue is generated from its operations in Singapore and Malaysia.

Share on Social Networks: